The problem is that it is easy to IPO when an industry is booming and almost impossible when it is getting smashed. But like in the mining industry, only in boom times the funding can be secured which means now many of the small cap bios, such as Precision BIO that got in trouble and got " bailed out " by IMU, can't continue and when the tide changes a huge tech-gap, like resources squeeze due to under developing of projects, will occur. Anyone surviving the current Bio-tech downturn should come out as a huge winner if data are impressive.
GLTA
CHM Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)